ATE201452T1 - Verwendung einer exonuklease und/oder einer glykosylase als ergänzung zu einem antipolymeraseantikörper für die verbesserung der spezifität der polymerasekettenraktion - Google Patents

Verwendung einer exonuklease und/oder einer glykosylase als ergänzung zu einem antipolymeraseantikörper für die verbesserung der spezifität der polymerasekettenraktion

Info

Publication number
ATE201452T1
ATE201452T1 AT96300791T AT96300791T ATE201452T1 AT E201452 T1 ATE201452 T1 AT E201452T1 AT 96300791 T AT96300791 T AT 96300791T AT 96300791 T AT96300791 T AT 96300791T AT E201452 T1 ATE201452 T1 AT E201452T1
Authority
AT
Austria
Prior art keywords
glycosylase
exonuclease
antibody
antipolymerase
raction
Prior art date
Application number
AT96300791T
Other languages
English (en)
Inventor
John W H Sutherland
David R Patterson
Original Assignee
Johnson & Johnson Clin Diag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Clin Diag filed Critical Johnson & Johnson Clin Diag
Application granted granted Critical
Publication of ATE201452T1 publication Critical patent/ATE201452T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/30—Phosphoric diester hydrolysing, i.e. nuclease
    • C12Q2521/319—Exonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/50—Other enzymatic activities
    • C12Q2521/531—Glycosylase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00—Reactions of nucleic acids characterised by
    • C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113—PCR

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
AT96300791T 1995-02-07 1996-02-06 Verwendung einer exonuklease und/oder einer glykosylase als ergänzung zu einem antipolymeraseantikörper für die verbesserung der spezifität der polymerasekettenraktion ATE201452T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38501995A 1995-02-07 1995-02-07

Publications (1)

Publication Number Publication Date
ATE201452T1 true ATE201452T1 (de) 2001-06-15

Family

ID=23519709

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96300791T ATE201452T1 (de) 1995-02-07 1996-02-06 Verwendung einer exonuklease und/oder einer glykosylase als ergänzung zu einem antipolymeraseantikörper für die verbesserung der spezifität der polymerasekettenraktion

Country Status (15)

Country Link
US (1) US5985619A (de)
EP (1) EP0726324B1 (de)
JP (1) JPH08266298A (de)
KR (1) KR960031627A (de)
AT (1) ATE201452T1 (de)
AU (1) AU709788B2 (de)
CA (1) CA2168712A1 (de)
DE (1) DE69612885T2 (de)
DK (1) DK0726324T3 (de)
ES (1) ES2156978T3 (de)
FI (1) FI960540L (de)
GR (1) GR3036391T3 (de)
NO (1) NO960484L (de)
PT (1) PT726324E (de)
SI (1) SI0726324T1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2292039A1 (en) * 1997-05-28 1998-12-03 The Walter And Eliza Hall Institute Of Medical Research Nucleic acid diagnostics based on mass spectrometry or mass separation and base specific cleavage
US6300075B1 (en) * 1999-02-03 2001-10-09 Ortho-Clinical Diagnostics, Inc Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid
US7074556B2 (en) * 1999-03-02 2006-07-11 Invitrogen Corporation cDNA synthesis improvements
FR2803601A1 (fr) * 2000-01-11 2001-07-13 Inst Nat Sante Rech Med Utilisation de l'exonuclease iii dans des reactions d'amplification par polymerase de fragments d'adn
EP1275735A1 (de) 2001-07-11 2003-01-15 Roche Diagnostics GmbH Zusammensetzung und Methode zur 'Hot start' Nukleinsäureamplifizierung
US20040152072A1 (en) * 2002-07-30 2004-08-05 Invitrogen Corporation Reverse transcription
EP1757705B1 (de) 2003-05-01 2009-01-14 Veridex LLC Intraoperativer Lymphknotentest
MXPA06014175A (es) * 2004-06-04 2007-05-09 Johnson & Johnson Diagnostico o pronostico del curso del cancer de mama.
US20070154889A1 (en) * 2004-06-25 2007-07-05 Veridex, Llc Methods and reagents for the detection of melanoma
CN103172700B (zh) * 2006-02-27 2014-12-17 霍夫曼-拉罗奇有限公司 经由镁螯合的pcr热启动
EP3167900B1 (de) 2006-03-29 2018-11-21 Merial Limited Impfstoff gegen streptokokken
CA2658520C (en) 2008-03-19 2016-11-08 F. Hoffmann-La Roche Ag Nucleic acid amplification in the presence of modified randomers
US8258111B2 (en) 2008-05-08 2012-09-04 The Johns Hopkins University Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
US7910720B2 (en) * 2008-09-09 2011-03-22 Roche Diagnostics Operations, Inc. Polyanion for improved nucleic acid amplification
WO2010135692A2 (en) 2009-05-22 2010-11-25 Asuragen, Inc. Mirna biomarkers of prostate disease
IL206810A (en) 2009-07-08 2015-07-30 Janssen Diagnostics Llc Methods for identifying melanoma and kits for using these methods
CN102725632A (zh) 2009-08-28 2012-10-10 奥斯瑞根公司 肺病的miRNA生物标志物
CA2817882C (en) 2010-11-17 2022-08-23 Asuragen, Inc. Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms
US9868992B2 (en) 2013-03-15 2018-01-16 Baylor Research Institute Tissue and blood-based miRNA biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer
US9758835B2 (en) 2013-03-15 2017-09-12 Baylor Research Institute Ulcerative colitis (UC)-associated colorectal neoplasia markers
CN122038564A (zh) 2014-01-05 2026-05-15 G·索兹 使用mirna比率确定肺癌
US10619210B2 (en) 2014-02-07 2020-04-14 The Johns Hopkins University Predicting response to epigenetic drug therapy
GB201414745D0 (en) 2014-08-19 2014-10-01 Articzymes As Exonucleases
WO2016094330A2 (en) 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
EP3292214A1 (de) 2015-05-04 2018-03-14 Academisch Medisch Centrum Verfahren zur quantifizierung von mirnas mittels normalisierung
US10081829B1 (en) 2017-06-13 2018-09-25 Genetics Research, Llc Detection of targeted sequence regions
JP2019198259A (ja) * 2018-05-15 2019-11-21 株式会社島津製作所 1ステップrt−pcr法
US20220145380A1 (en) * 2019-01-31 2022-05-12 Children's Medical Center Corporation Cost-effective detection of low frequency genetic variation
US11224850B2 (en) 2019-02-20 2022-01-18 Genetics Research, Llc Regulated multiplex reactions in a single tube
EP3719144A1 (de) 2019-04-05 2020-10-07 Fundación para la Investigación Biomédica del Hospital Universitario de la Paz (FIBHULP) Mir-151a-3p als universelle endogene steuerung zur exosomenladungsnormalisierung
US20220267857A1 (en) 2019-07-19 2022-08-25 Fundación Para La Investigación Biomédikca Del Hospital Universitario La Paz (Fibhulp) Method for determining the response to treatment of a patient affected by non-small cell lung carcinoma (nsclc)
WO2021120095A1 (zh) * 2019-12-19 2021-06-24 深圳华大生命科学研究院 抗聚合酶的单克隆抗体及其应用
US20250145989A1 (en) * 2022-01-26 2025-05-08 Seegene, Inc. Method for detecting target nucleic acids in sample
CN116773291B (zh) * 2023-03-31 2024-04-19 艾普拜生物科技(苏州)有限公司 一种石蜡切片dna预处理试剂及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2128323T3 (es) * 1990-07-24 1999-05-16 Hoffmann La Roche Reduccion de la amplificacion no-especifica durante la amplificacion in vitro del acido nucleico empleando bases de acido nucleico modificadas.
DE69128520T2 (de) * 1990-10-31 1998-07-09 Tosoh Corp Verfahren zum Nachweis oder Quantifizierung von Zielnukleinsäuren
CA2101119A1 (en) * 1992-08-17 1994-02-18 George T. Walker Exonuclease decontamination method
US5338671A (en) * 1992-10-07 1994-08-16 Eastman Kodak Company DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody
US5605796A (en) * 1994-07-19 1997-02-25 Behringwerke Ag Method for preventing amplification of nucleic acid contaminants in amplification mixtures using nuclease-receptor conjugates

Also Published As

Publication number Publication date
CA2168712A1 (en) 1996-08-08
EP0726324A2 (de) 1996-08-14
DE69612885D1 (de) 2001-06-28
AU709788B2 (en) 1999-09-09
EP0726324A3 (de) 1996-11-27
DK0726324T3 (da) 2001-07-30
FI960540A7 (fi) 1996-08-08
GR3036391T3 (en) 2001-11-30
NO960484L (no) 1996-08-08
NO960484D0 (no) 1996-02-06
US5985619A (en) 1999-11-16
ES2156978T3 (es) 2001-08-01
FI960540L (fi) 1996-08-08
SI0726324T1 (en) 2001-12-31
DE69612885T2 (de) 2001-09-13
JPH08266298A (ja) 1996-10-15
KR960031627A (ko) 1996-09-17
FI960540A0 (fi) 1996-02-06
PT726324E (pt) 2001-08-30
AU4339196A (en) 1996-08-15
EP0726324B1 (de) 2001-05-23

Similar Documents

Publication Publication Date Title
DE69612885D1 (de) Verwendung einer Exonuklease und/oder einer Glykosylase als Ergänzung zu einem Antipolymeraseantikörper für die Verbesserung der Spezifität der Polymerasekettenraktion
EA200100402A1 (ru) Способы амплификации и секвенирования нуклеиновых кислот
DE69334071D1 (de) Prostata-spezifisches membranantigen
PT669401E (pt) Amplificacao de sequencias compridas de acidos nucleicos
DK0675969T3 (da) Fremgangsmåde til mangfoldiggørelse af målrettede nucleinsyresegmenter under anvendelse af grupperet polymerase-kædereaktion
ATE147794T1 (de) Chemisches verfahren zur analyse von dns- sequenzen
ATE266102T1 (de) Verfahren zur koamplifikation einer zielnukleinsäure unter versendung eines volumenabscheidungsmittel in der reaktionszusammensetzung, testsatz und testvorrichtung
DK0543942T4 (da) Homogent assaysystem
ATE360093T1 (de) Reaktionsgemisch und verfahren für rt-pcr mittels einer homopolymeren nukleinsäure
BR9603563A (pt) Enzima termoestável quimicamente modificada processo para sua preparação processo para a amplificação de um ácido nucléico mistura reacional de amplificação e kit para conduzir uma reação em cadeia de polimerase
DE69301221D1 (de) Thermostabile DNA-Polymerase-Zusammensetzung die ein Temparatur-Inhibitor enthält, diagnostische Testkits und die Verwendung
ATE398187T1 (de) Verfahren zum nachweis von ziel-nukleinsäuren mittels pcr
ATE250226T1 (de) Aufbereitung einer gesamtblutprobe für die polymerase-kettenreaktion unter verwendung von ammoniumchlorid und carbonsäuren oder metall- carboxylaten zur selektiven lyse von roten blutzellen
ATE205259T1 (de) Reagenz und verfahren für reverse transkription bei hoher temperatur, verbunden mit einer polymerase-kettenreaktion
ATE178946T1 (de) Verbessertes verfahren für die quantifizierung von nukleinsäuren
DK0402997T3 (da) Fremgangsmåde til bestemmelse af nukleinsyre
ATE214819T1 (de) Steuerung von nukleinsäure- amplifikationsverfahren einschlie lich der polymerase-kettenreaktion
EP0751226A3 (de) Verfahren für die Amplifizierung von Nukleinsäure-Sequenzen
DE69019770D1 (de) Verfahren zur Reinigung, Vervielfachung und zum Nachweis einer Nukleinsäure.
KR102531590B1 (ko) 절단효소 인식부위의 미러링 결합에 의한 표적핵산의 검출 방법 및 핵산 검출용 조성물

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee